| View |
|
DRP-7257-08
|
Vitamin B1 + B6 + B12
|
Forte-B
|
100 mg/5 mg/50 mcg
|
Tablet
|
Vitamins
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
21 July 2022
|
07 July 2027
|
| View |
|
DRP-10897-02
|
Losartan potassium + Hydrochlorothiazide
|
None
|
100 mg/25 mg
|
Film Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)/Diuretic
|
Centurion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 October 2022
|
13 December 2026
|
| View |
|
DRP-10929-15
|
Norepinephrine (As Bitartrate)
|
Normeed
|
1mg/mL (4mg/4mL)
|
Solution For Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Mackur Laboratories Limited
|
India
|
Automatic Renewal
|
15 August 2022
|
31 January 2027
|
| View |
|
DRP-3779-02
|
Thiamine Mononitrate (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
B-Rite
|
100 mg/ 5 mg/ 50 mcg
|
Tablet
|
VITAMIN
|
Pharmatechnica Laboratory, Inc.
|
Philippines
|
CLIDP Conversion
|
12 May 2022
|
27 April 2026
|
| View |
|
DRP-6527-08
|
Meropenem (As Trihydrate)
|
Plemonem 1000
|
1 g
|
Powder for Solution for Injection (IV)
|
Antibacterial (Carbapenem)
|
Brooks Steriscience Limited
|
India
|
Initial (Variation)
|
02 February 2024
|
18 May 2027
|
| View |
|
DRP-10929-12
|
Norepinephrine (As Bitartrate)
|
Exeprin
|
1mg/mL (4mg/4mL)
|
Solution For Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Mackur Laboratories Limited
|
India
|
Automatic Renewal
|
21 July 2022
|
31 January 2027
|
| View |
|
DRP-10868-12
|
Ascorbic Acid + Zinc
|
Gift Cee
|
533.40mg (equivalent to 600mg Sodium Ascorbate)+ 10mg (equivalent to 27.45mg Zinc Sulfate)
|
Capsule
|
VITAMIN/MINERAL
|
Eurasia Research Pharma Corporation
|
Philippines
|
CLIDP Conversion
|
19 October 2022
|
30 October 2025
|
| View |
|
DRP-7128-04
|
Sitagliptin (as phosphate monohydrate)
|
None
|
100 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
16 February 2022
|
20 April 2026
|
| View |
|
DRP-12037-03
|
Sitagliptin (as phosphate monohydrate) + Metformin hydrochloride
|
None
|
50 mg/1 g
|
Film-Coated Tablet
|
Dipeptidyl peptidase 4 (DPP-4) inhibitor/Blood glucose lowering drug (Biguanide)
|
Sai Mirra Innopharm Pvt. Ltd.
|
India
|
CLIDP Conversion
|
29 July 2022
|
02 June 2027
|
| View |
|
DRP-11154-11
|
Nicardipine Hydrochloride
|
Blicarpine
|
1 mg/mL (10 mg/10 mL)
|
Solution for Injection (IV Infusion
|
Calcium Channel Blocker (Dihydropyridine derivative)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
01 August 2022
|
11 February 2027
|
| View |
|
DRP-9078-05
|
Sitagliptin (as phosphate)
|
Sitplixin 50
|
50 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
09 August 2022
|
31 October 2025
|
| View |
|
HRP-185-09
|
Ascorbic Acid (as Sodium Ascorbate)
|
Crystal C Alkaline
|
500 mg
|
Capsule (equivalent to 562.43 mg Sodium Ascorbate)
|
Vitamin
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
19 February 2023
|
28 January 2028
|
| View |
|
DRP-1419-08
|
Salbutamol (as Sulfate) + Ipratropium (as Bromide)
|
Pulmodual
|
2.5 mg/500 mcg per 2.5 mL
|
Solution For Inhalation
|
-
|
Ahlcon Parenterals (India) Limited
|
India
|
Automatic Renewal
|
08 April 2022
|
19 May 2027
|
| View |
|
DRP-9317-01
|
Esomeprazole (as magnesium dihydrate)
|
Genprazole
|
40mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Acme Formulation Pvt. Ltd.
|
India
|
CLIDP Conversion
|
31 March 2022
|
25 November 2025
|
| View |
|
DRP-3199-08
|
Telmisartan + Hydrochlorothiazide
|
Telarb Plus
|
40 mg/12.5 mg
|
Tablet
|
-
|
Theon Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
03 May 2022
|
23 August 2026
|
| View |
|
DRP-11847-01
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Acantha Max
|
50 mg/ 1 g
|
Film-Coated Tablet
|
-
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
08 July 2022
|
10 May 2027
|
| View |
|
DRP-2672-14
|
Clopidogrel (as bisulfate)
|
Unbranded
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic (Platelet Aggregation Inhibitors)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
09 May 2022
|
04 January 2029
|
| View |
|
DRP-11547-02
|
Paracetamol
|
Paraway
|
10 mg/mL (1g/100 mL)
|
Solution for Injection (IV Infusion)
|
-
|
Genuone Sciences Inc.
|
Korea
|
CLIDP Conversion
|
08 July 2022
|
30 March 2027
|
| View |
|
DRP-9391-03
|
Telmisartan
|
Teliwise 80c
|
80 mg
|
Film-Coated Tablet
|
-
|
Mars Therapeutics Private Limited
|
India
|
CLIDP Conversion
|
16 February 2022
|
02 March 2026
|
| View |
|
DRP-8586-10
|
Trimetazidine dihydrochloride
|
Angitrim
|
35 mg
|
Modified-Release Tablet
|
Anti-Angina
|
Stallion Laboratories Pvt. Ltd
|
India
|
Renewal
|
25 April 2024
|
18 December 2029
|